[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354003-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354003-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeting-the-gut-microbiota-metabolite-immune-axis-in-cancer-immunotherapy-mechanistic-interplay-therapeutic-strategies-and-translational-applications-a-narrative-review","Targeting the gut microbiota-metabolite-immune axis in cancer immunotherapy - mechanistic interplay, therapeutic strategies, and translational applications - a narrative review","","Microbiota and their metabolites form a dynamic regulatory network that shapes the tumor microenvironment and immune-cell function, making this gut microbiota–metabolite–immune axis a key target in cancer immunotherapy. Despite progress with immune checkpoint inhibitors (ICIs), durable response is restricted by primary or acquired resistance. This narrative review summarizes mechanistic insights into how this axis governs ICI responsiveness across cancer types and compiles current microbiota-targeted interventions. It also evaluates translational approaches to improve efficacy and overcome resistance, highlighting the role of precision, multi-omics, and large-scale clinical trials.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-the-gut-microbiota-metabolite-immune-axis-in-cancer-immunotherapy-mechanistic-interplay-therapeutic-strategies-and-translational-applications-a-narrative-review/354003/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-the-gut-microbiota-metabolite-immune-axis-in-cancer-immunotherapy-mechanistic-interplay-therapeutic-strategies-and-translational-applications-a-narrative-review/354003.png","ImageObject",300,407,{"name":42,"@type":43},"Alex Sinclair","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is the gut microbiota-metabolite-immune axis considered important in cancer immunotherapy?","Question",{"text":63,"@type":64},"Because microbiota and their metabolites dynamically regulate the tumor microenvironment and immune-cell functionality. This axis has been shown to influence how well immune checkpoint inhibitors work.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What problem limits the effectiveness of immune checkpoint inhibitors (ICIs)?",{"text":68,"@type":64},"Primary or acquired resistance reduces clinical efficacy in a substantial proportion of patients, including cases where initial responders later develop acquired resistance.",{"name":70,"@type":61,"acceptedAnswer":71},"Which therapeutic strategies does the review discuss for improving ICI outcomes?",{"text":72,"@type":64},"It evaluates translational microbiota-targeted approaches such as fecal microbiota transplantation, probiotic supplementation, and engineered microbes as adjuvants to enhance ICI efficacy and counter resistance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354003,1790170840,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Review Article  \nTargeting the gut microbiota-metabolite-immune axis in cancer immunotherapy: mechanistic interplay, therapeutic strategies, and translational applications-a narrative review  \nMeng Huang1, Yunzhao Chen2, Xiaobin Cui1  \n1Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China; 2Cancer Center, Department of Pathology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, China  \nContributions: (I) Conception and design: All authors; (II) Administrative support: X Cui, M Huang; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: M Huang; (V) Data analysis and interpretation: M Huang, X Cui; (VI) Manuscript writing: All authors;  \n(VII) Final approval of manuscript: All authors.  \nCorrespondence to: Yunzhao Chen, MD. Cancer Center, Department of Pathology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, 158 Shangtang Road, Shangcheng District, Hangzhou 310014, China. Email: [cyz0515@sina.com](cyz0515@sina.com); Xiaobin Cui, MD. Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, 321 Zhongshan Road, Gulou District, Nanjing 210008, China. Email: [cuixiaobin4363@foxmail.com](cuixiaobin4363@foxmail.com).  \nBackground and Objective: Microbiota and their metabolites form a dynamic regulatory network that modulates the tumor microenvironment (TME) and immune cell functionality, emerging as critical targets in cancer immunotherapy. Despite remarkable advances in immune checkpoint inhibitors (ICIs), clinical efficacy remains limited by primary or acquired resistance in a substantial proportion of patients.  \nAccumulating evidence indicates that the gut microbiota-metabolite-immune axis is a critical determinant of ICI responsiveness, but the underlying molecular mechanisms and tumor-specific regulatory patterns remain incompletely elucidated. This narrative review aims to systematically dissect the mechanistic interplay of this axis across diverse cancer types and synthesize current microbiota-targeted therapeutic strategies for  \nimproved immunotherapy outcomes.  \nMethods: We conducted a systematic literature search of PubMed for studies published between January 2019 and December 2025, with a particular focus on basic and translational research elucidating the roles of  \ngut microbiota and their metabolites in cancer immunotherapy across various malignancies.  \nKey Content and Findings: This review elucidates the molecular mechanisms by which core metabolites regulate antitumor immunity, synthesizes characteristic microbial signatures across gastrointestinal and nongastrointestinal cancers. Furthermore, we evaluate the translational potential of intervention strategies, including fecal microbiota transplantation, probiotic supplementation, and engineered microbes, as adjuvants  \nto enhance ICI efficacy and overcome resistance.  \nConclusions: Microbiota-based personalized therapeutic strategies are increasingly recognized as promising tools to modulate antitumor immunity and improve immunotherapy outcomes. Systematic profiling of the gut microbiota-metabolite-immune axis across cancer types will facilitate the development of precision interventions to overcome ICI resistance. Future research integrating multi-omics approaches and large-scale clinical trials is pivotal to translate mechanistic insights into clinically viable therapies, ultimately  \nrevolutionizing the landscape of cancer immuno-oncology.  \nKeywords: Cancer; immunotherapy; immune checkpoint inhibitors (ICIs); gut microbiota; gut microbiota  \nderived metabolites  \nSubmitted Sep 09, 2025. Accepted for publication Jan 13, 2026. Published online Feb 27, 2026.  \ndoi: 10.21037/tcr-2025-1992  \nView this article at: [https://dx.doi.org/10.21037/tcr-2025-1992](https://dx.doi.org/10.21037/tcr-2025-1","cbCairhsakf7k2pl","https://ap.wps.com/l/cbCairhsakf7k2pl","pdf",836233,"English","# Background and Objective\n## Methods\n## Key Content and Findings\n## Conclusions\n# Introduction\n## Immune checkpoints and emerging targets\n## ICI resistance as a clinical challenge","[{\"question\":\"Why is the gut microbiota-metabolite-immune axis considered important in cancer immunotherapy?\",\"answer\":\"Because microbiota and their metabolites dynamically regulate the tumor microenvironment and immune-cell functionality. This axis has been shown to influence how well immune checkpoint inhibitors work.\"},{\"question\":\"What problem limits the effectiveness of immune checkpoint inhibitors (ICIs)?\",\"answer\":\"Primary or acquired resistance reduces clinical efficacy in a substantial proportion of patients, including cases where initial responders later develop acquired resistance.\"},{\"question\":\"Which therapeutic strategies does the review discuss for improving ICI outcomes?\",\"answer\":\"It evaluates translational microbiota-targeted approaches such as fecal microbiota transplantation, probiotic supplementation, and engineered microbes as adjuvants to enhance ICI efficacy and counter resistance.\"}]","Targeting the gut microbiota-metabolite-immune axis in cancer immunotherapy - mechanistic interplay, therapeutic strategies, and translational applications - a narrative review | PDF",1790108432,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/672bf59c6b16fff35772b622a4f75514.webp",983,1287,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4833cbd29189ebff700b37ea521422fd.webp",982,1286,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cdc42bb759da81bb4a509f863007c300.webp",981,1284,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9eb1452fa248f91c9beaafecf161ee72.webp",980,1283]